As of 2023, the actual sales of non-steroids antiinflammatory and antirheumatic medicines in Italy stood at 163.2 million Euros. The forecast data projects a steady increase in sales from 2024 to 2028, beginning at 167.6 million Euros in 2024 and reaching up to 181.0 million Euros by 2028. This represents a compound annual growth rate (CAGR) of approximately 2.1% over this five-year period.
Year-on-year percentage variations highlight a consistent upward trend in the market. Between 2024 and 2025, sales are expected to increase by around 2.7%, with a slightly declining growth rate to 1.5% by 2028.
Future trends to watch for:
- Potential introduction of new generic options that might impact pricing and market shares.
- Technological advancements in drug formulations enhancing therapeutic efficacy and consumer acceptance.
- Regulatory changes regarding drug approvals and healthcare policies impacting market dynamics.
